Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc. (ETON), sold 100,000 shares at $62.65 ($6.1M) on 2026-08-19, disclosed to the SEC on 2026-08-20.
Open-market sale of $6.1M ETON by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.65 | 8,978 | $562K | 9.2% |
| 2 | $60.17 | 47,307 | $2.8M | 46.8% |
| 3 | $61.11 | 36,373 | $2.2M | 36.5% |
| 4 | $62.12 | 7,342 | $456K | 7.5% |
| Total | $60.88 avg | 100,000 | $6.1M | 100% |
| Filing → |
| ETON | BUY | 2022-09-23 | $21K | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |
| ETON | BUY | 2021-06-03 | $30K | — | Filing → |